These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 10323317
1. L-threo-3,4-dihydroxyphenylserine enhances the orthostatic responses of plasma renin activity and angiotensin II in multiple system atrophy. Yoshizawa T, Fujita T, Mizusawa H, Shoji S. J Neurol; 1999 Mar; 246(3):193-7. PubMed ID: 10323317 [Abstract] [Full Text] [Related]
2. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure. Mathias CJ, Senard JM, Braune S, Watson L, Aragishi A, Keeling JE, Taylor MD. Clin Auton Res; 2001 Aug; 11(4):235-42. PubMed ID: 11710796 [Abstract] [Full Text] [Related]
3. [Effects of L-threo-Dops on orthostatic hypotension in Parkinson's disease]. Yanagisawa N, Ikeda S, Hashimoto T, Hanyu N, Nakagawa S, Fujimori N, Ushiyama M. No To Shinkei; 1998 Feb; 50(2):157-63. PubMed ID: 9513205 [Abstract] [Full Text] [Related]
4. Effect of L-threo-3,4-dihydroxyphenylserine on muscle sympathetic nerve activity in humans. Iwase S, Mano T, Kunimoto M, Saito M. J Auton Nerv Syst; 1992 Jun 15; 39(2):159-67. PubMed ID: 1430796 [Abstract] [Full Text] [Related]
5. Treatment of orthostatic hypotension in Shy-Drager syndrome with DL-threo-3,4-dihydroxyphenylserine: a case report. Sakoda S, Suzuki T, Higa S, Ueji M, Kishimoto S, Matsumoto M, Yoneda S. Eur Neurol; 1985 Jun 15; 24(5):330-4. PubMed ID: 3932074 [Abstract] [Full Text] [Related]
6. Improved orthostatic tolerance in familial amyloidotic polyneuropathy with unnatural noradrenaline precursor L-threo-3,4-dihydroxyphenylserine. Carvalho MJ, van den Meiracker AH, Boomsma F, Man in 't Veld AJ, Freitas J, Costa O, de Freitas AF. J Auton Nerv Syst; 1997 Jan 12; 62(1-2):63-71. PubMed ID: 9021651 [Abstract] [Full Text] [Related]
7. d,l-threo-3,4-dihydroxyphenylserine restores sympathetic control and cures orthostatic hypotension in dopamine beta-hydroxylase deficiency. Man in 't Veld AJ, Boomsma F, van den Meiracker AH, Julien C, Lenders J, Schalekamp MA. J Hypertens Suppl; 1988 Dec 12; 6(4):S547-9. PubMed ID: 3149290 [Abstract] [Full Text] [Related]
8. The treatment of neurogenic orthostatic hypotension with 3,4-DL-threo-dihydroxyphenylserine: a randomized, placebo-controlled, crossover trial. Freeman R, Landsberg L, Young J. Neurology; 1999 Dec 10; 53(9):2151-7. PubMed ID: 10599797 [Abstract] [Full Text] [Related]
9. Clinical effects of L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients. Akizawa T, Koshikawa S, Iida N, Marumo F, Akiba T, Kawaguchi Y, Imada A, Yamazaki C, Suzuki M, Tubakihara Y. Nephron; 2002 Apr 10; 90(4):384-90. PubMed ID: 11961396 [Abstract] [Full Text] [Related]
10. Studies of neurocirculatory effects of long-term L-threo-3,4-dihydroxyphenylserine administration in a patient with familial amyloidotic polyneuropathy. Azuma T, Suzuki T, Mizuno R, Tsujino S, Kishimoto S, Mizuta E, Ichikawa K. Acta Neurol Scand; 1988 May 10; 77(5):409-13. PubMed ID: 3137768 [Abstract] [Full Text] [Related]
11. Norepinephrine precursor therapy in neurogenic orthostatic hypotension. Kaufmann H, Saadia D, Voustianiouk A, Goldstein DS, Holmes C, Yahr MD, Nardin R, Freeman R. Circulation; 2003 Aug 12; 108(6):724-8. PubMed ID: 12885750 [Abstract] [Full Text] [Related]
12. The effects of the noradrenaline precursor, L-threo-3,4-dihydroxyphenylserine, in children with orthostatic intolerance. Tanaka H, Yamaguchi H, Mino M. Clin Auton Res; 1996 Aug 12; 6(4):189-93. PubMed ID: 8902314 [Abstract] [Full Text] [Related]
13. Renin responses in patients with orthostatic hypotension: case reports. Asato C, Muratani H, Touma T, Kawazoe N, Kimura Y, Takishita S, Fukiyama K. Angiology; 1993 Jul 12; 44(7):586-92. PubMed ID: 8328690 [Abstract] [Full Text] [Related]
14. Impaired peripheral vasoconstrictor response to orthostatic stress in patients with multiple system atrophy. Suzuki J, Nakamura T, Hirayama M, Mizutani Y, Okada A, Ito M, Watanabe H, Sobue G. Parkinsonism Relat Disord; 2015 Aug 12; 21(8):917-22. PubMed ID: 26054882 [Abstract] [Full Text] [Related]
15. Effects of L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients. Iida N, Koshikawa S, Akizawa T, Tsubakihara Y, Marumo F, Akiba T, Kawaguchi Y, Imada A, Yamazaki C, Suzuki M. Am J Nephrol; 2002 Aug 12; 22(4):338-46. PubMed ID: 12169865 [Abstract] [Full Text] [Related]
16. Postural changes in plasma renin activity and responses to vasoactive drugs in a case of Shy-Drager syndrome. Mathias CJ, Matthews WB, Spalding JM. J Neurol Neurosurg Psychiatry; 1977 Feb 12; 40(2):138-43. PubMed ID: 864477 [Abstract] [Full Text] [Related]
17. Beneficial attenuating effect of L-threo-3,4-dihydroxyphenylserine on postural hypotension in anesthetized rats. Satoh S, Oyabe A, Tanno M, Suzuki-Kusaba M. Arzneimittelforschung; 1989 Sep 12; 39(9):1123-9. PubMed ID: 2511849 [Abstract] [Full Text] [Related]
18. DL-Threo-3,4-dihydroxyphenylserine does not exert a pressor effect in orthostatic hypotension. Hoeldtke RD, Cilmi KM, Mattis-Graves K. Clin Pharmacol Ther; 1984 Sep 12; 36(3):302-6. PubMed ID: 6432398 [Abstract] [Full Text] [Related]
19. Differential effect of L-threo-3,4-dihydroxyphenylserine in pure autonomic failure and multiple system atrophy with autonomic failure. Kaufmann H, Oribe E, Yahr MD. J Neural Transm Park Dis Dement Sect; 1991 Sep 12; 3(2):143-8. PubMed ID: 1910486 [Abstract] [Full Text] [Related]
20. Effect of L-threo-3, 4-dihydroxyphenylserine on orthostatic hypotension in a patient with spinal cord injury. Muneta S, Iwata T, Hiwada K, Murakami E, Sato Y, Imamura Y. Jpn Circ J; 1992 Mar 12; 56(3):243-7. PubMed ID: 1552652 [Abstract] [Full Text] [Related] Page: [Next] [New Search]